Eurocor GmbH, the wholly-owned subsidiary of Opto Circuits (India), has launched a combination medical device called Magical – a bare metal cobalt chromium stent pre-mounted on a drug eluting balloon in India. The technology has already received registration from DCGI. Live workshops were conducted at Desun Hospital and Hart Institute and B M Birla Heart Research Centre in Kolkata. The cases were performed by Dr Rosli Mohd Ali from National Heart Centre, Malaysia and Dr M S Hiremath from Ruby Hall Clinic, Pune, using Magical.

Magical is a drug involving combination device (DEB, Drug Eluting Balloon plus BMS, Bare Metal Stent) to effectively deter the occurrence of restenosis and late stent thrombosis, two perilous risks associated with regular angioplasty treatments. Eurocor is a pioneer in this technology which is a successful alternative to drug-eluting stents in certain applications and its greatest advantage is reduced anti-platelet therapy, providing better quality of life after stenting.

Magical – the paclitaxel coated cobalt chromium stent system provides the thinnest stent strut design (0.0025”) for rapid healing. This is an option to significantly enhance the long-term quality of patient treatment. While the Magical stent is expanded and deployed into the arterial wall at the lesion site, the stent delivery balloon is kept inside the expanded stent, inflated up to one minute for an optimal drug release to the coronary artery lesion. Paclitaxel is absorbed by the arterial wall at the lesion site.

A symposium was held at the Park Hotel were leading interventional cardiologists from around the country and abroad had gathered to discuss the sue of Dior and Magical as the latest technologies in the treatment of occluded coronary arteries. The products manufactured by Eurocor in Bonn are used in minimally invasive cardiovascular and peripheral surgery and comply with biological and biomechanical principles to offer highly flexible, adaptable solutions.